Search Results for: "Food and Drug Administration"

FDA approves new treatment for HIV


The U.S. Food and Drug Administration today approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older. The CDC estimates that 1.2 million persons ages 13 years and older are living…

Hepatitis C in Corrections – A New Resource for Incarcerated People

Rich Feffer, Correctional Health Programs Manager, Hepatitis Education Project

A disproportionate number of people with hepatitis C (HCV) in the U.S. are or have been inmates in jails and prisons. Correctional settings therefore present significant opportunities to provide hepatitis prevention, testing, care, and treatment interventions. To help incarcerated people understand HCV, the National Hepatitis Corrections Network (NHCN)  has introduced a new resource to assist…

HHS World Hepatitis Day Observance Showcased Progress & Collaboration


On July 28, the U.S. Department of Health and Human Services (HHS) hosted the fifth annual observance of World Hepatitis Day to continue raising awareness of the burden of viral hepatitis both here in the U.S. and around the world. Globally, viral hepatitis affects 400 million people and kills over 1.4 million people annually , and…

FDA Reaches Out to Minorities During Hepatitis Awareness Month


Did you know that millions of Americans (mostly baby boomers) are living with chronic Hepatitis and up to 2/3 may not even know they are infected? Annually, in May, the public health community commemorates “Hepatitis Awareness Month” to bring attention to this disease, its symptoms, testing, and treatment options. This year, we are working with…

FDA Invites Comments on Proposal to Revise Lifetime Deferral on Blood Donation by Gay Men


In a Federal Register notice published Friday, May 15, 2015, the Food and Drug Administration (FDA) is inviting public comments on the following draft recommendations: Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products [PDF 135KB]. This draft guidance, to establishments that collect blood or blood components, proposes…

New Hepatitis C Treatments Have High Cure Rates for African Americans

CDC heptatis image AfricanAm-186x260

The epidemic of chronic hepatitis C virus (HCV) infection impacts over 3 million individuals in the United States, and over 50% of infected people are undiagnosed. In an effort to increase the number of people who are aware of their HCV infection and link them to care, in 2012 the U.S. Centers for Disease Control…

Medicare Announces Coverage for Annual HIV Test

CMS Logo

The Centers for Medicare and Medicaid Services (CMS) announced this week that it has expanded coverage to include one, annual voluntary screening for HIV infection for all adolescent and adult Medicare beneficiaries between the ages of 15 and 65, without regard to perceived risk.  Coverage for pregnant Medicare beneficiaries will remain unchanged. The addition of…

NIH-led study to assess community-based hepatitis C treatment in Washington, D.C.

nih logo

For Immediate Release: Friday, March 6, 2015 Officials from the National Institutes of Health and the city of Washington, D.C., launched a clinical trial to examine whether primary care physicians and other health care providers, such as nurse practitioners and physician assistants, can use a new antiviral therapy as effectively as specialist physicians to treat…